Thromboelastography in Non-elective Cesarean Delivery

Trial ID or NCT#

NCT01514591

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Official Title

Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery

Eligibility Criteria

Ages Eligible for Study: 18 Years to 40 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - Obstetric in-patients - Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean - Patients of all ethnic backgrounds will be included - Singleton pregnancy - ASA 1 or 2
Exclusion Criteria:
  1. - Patients with underlying coagulation disorders. - Patients with thrombocytopenia (platelet count <100). - Patients with pregnancy-induced hypertension, pre-eclampsia. - Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants. - Patients requiring elective Cesarean delivery. - Patients with significant obstetric or medical disease. - No patients <18 years of age will be recruited.

Investigator(s)

Farheen Mirza

Contact us to find out if this trial is right for you.

Contact

Alexander J Butwick, MBBS, FRCA
6507368513